Novartis India has informed that it enclosed intimation dated December 21, 2023 received from Link Intime India, Registrar and Transfer Agent, providing information regarding issue of duplicate share certificate in favour of shareholder of the Company. Further, in accordance with the SEBI Notification No. SEBI/LAD-NRO/GN/2022/66 dated January 24, 2022, read with SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated January 25, 2022, letter of confirmations in lieu of the physical share certificate will be issued to the said shareholder of the Company within the prescribed timelines.
The above information is a part of company’s filings submitted to BSE.
